Impact Of Metformin In Rectal Cancer Patients

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

June 15, 2025

Study Completion Date

July 15, 2025

Conditions

Rectal Cancer Patients

Interventions

DRUG

Metformin

1000mg of metformin twice daily by mouth

Trial Locations (2)

Minia Oncology Center, Minya

Minia University Hospital, Minya

All Listed Sponsors

lead

Minia University

OTHER

NCT06728982 - Impact Of Metformin In Rectal Cancer Patients | Biotech Hunter | Biotech Hunter